P2X3 receptors and sensitization of autonomic reflexes

被引:25
|
作者
Ford, Anthony P. [1 ]
Undem, Bradley J. [2 ]
Birder, Lori A. [3 ]
Grundy, David [4 ]
Pijacka, Wioletta [5 ]
Paton, Julian F. R. [5 ]
机构
[1] Afferent Pharmaceut, San Mateo, CA 94403 USA
[2] Johns Hopkins Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21224 USA
[3] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA
[4] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England
[5] Univ Bristol, Sch Physiol & Pharmacol, Bristol CardioVasc, Bristol BS8 1TD, Avon, England
来源
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL | 2015年 / 191卷
关键词
Sensitization; Hyperreflexia; Airway hyperreactivity; Bladder; Gastrointestinal; Autonomic; Carotid hypertonicity; P2X3; receptors; Sympathetic activity; BLADDER UMBRELLA CELLS; PURINERGIC NEUROMUSCULAR-TRANSMISSION; INTESTINAL AFFERENT HYPERSENSITIVITY; CAROTID-BODY CHEMORECEPTORS; ENTERIC NERVOUS-SYSTEM; PIG DISTAL COLON; SMOOTH-MUSCLE; URINARY-BLADDER; P2X(7) RECEPTOR; SENSORY NEURONS;
D O I
10.1016/j.autneu.2015.04.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A great deal of basic and applied physiology and pharmacology in sensory and autonomic neuroscience has teased apart mechanisms that drive normal perception of mechanical, thermal and chemical signals and convey them to CNS, the distinction of fiber types and receptors and channels that mediate them, and how they may become dysfunctional or maladaptive in disease. Likewise, regulation of efferent autonomic traffic to control organ reflexes has been well studied. In both afferent and efferent limbs, a wide array of potential therapeutic mechanisms has surfaced, some of which have progressed into clinic, if not full regrastration. One conversation that has been less well progressed relates to how the afferent limb and its sensitization shapes the efferent outputs, and where modulation may offer new therapeutic avenues, especially for poorly addressed and common signs and symptoms of disease. Therapeutics for CV disease (HF, hypertension), respiratory disease (asthma, COPD), urological disease (OAB), GI disease (IBS), and inter alia, have largely focused on the efferent control of effector cells to modulate movement, contraction and secretion; medicinal needs remain with limits to efficacy, AEs and treatment resistance being common. We now must turn, in the quest for improved therapeutics, to understand how sensation from these organs becomes maladapted and sensitized in disease, and what opportunities may arise for improved therapeutics given the abundance of targets, many pharmacologically untapped, on the afferent side. One might look at the treatment resistant hypertension and the emerging benefit of renal denervation; or urinary bladder overactivity/neurogenic bladder and the emergence of neuromodulation, capsaicin instillation or botox injections to attenuate sensitized reflexes, as examples of merely the start of such progress. This review examines this topic more deeply, as applies to four major organ systems all sharing a great need from unsatisfied patients. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 50 条
  • [21] Neurochemical identification of enteric neurons expressing P2X3 receptors in the guinea-pig ileum
    Van Nassauw, L
    Brouns, I
    Adriaensen, D
    Burnstock, G
    Timmermans, JP
    HISTOCHEMISTRY AND CELL BIOLOGY, 2002, 118 (03) : 193 - 203
  • [22] Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats
    Kaan, Timothy K. Y.
    Yip, Ping K.
    Patel, Sital
    Davies, Meirion
    Marchand, Fabien
    Cockayne, Debra A.
    Nunn, Philip A.
    Dickenson, Anthony H.
    Ford, Anthony P. D. W.
    Zhong, Yu
    Malcangio, Marzia
    McMahon, Stephen B.
    BRAIN, 2010, 133 : 2549 - 2564
  • [23] Deletion of P2X3 receptors blunts gastro-oesophageal sensation in mice
    Mcilwrath, S. L.
    Davis, B. M.
    Bielefeldt, K.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (08) : 890 - +
  • [24] The therapeutic promise of ATP antagonism at P2X3 receptors in respiratory and urological disorders
    Ford, Anthony P.
    Undem, Bradley J.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2013, 7
  • [25] Identification of P2X3 and P2X7 Purinergic Receptors Activated by ATP in Rat Lacrimal Gland
    Hodges, Robin R.
    Vrouvlianis, Joanna
    Scott, Rachel
    Dartt, Darlene A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (06) : 3254 - 3263
  • [26] ATP-Gated P2X3 Receptors Are Specialised Sensors of the Extracellular Environment
    Fabbretti, Elsa
    PROTEIN REVIEWS, VOL 19, 2017, 1051 : 7 - 16
  • [27] Expression of P2X3 purinoceptors in suburothelial myofibroblasts of the normal human urinary bladder
    Liu, Fei
    Takahashi, Norio
    Yamaguchi, Osamu
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (06) : 570 - 575
  • [28] Stable, synthetic analogs of diadenosine tetraphosphate inhibit rat and human P2X3 receptors and inflammatory pain
    Viatchenko-Karpinski, Viacheslav
    Novosolova, Natalia
    Ishchenko, Yevheniia
    Azhar, M. Ameruddin
    Wright, Michael
    Tsintsadze, Vera
    Kamal, Ahmed
    Burnashev, Nail
    Miller, Andrew D.
    Voitenko, Nana
    Giniatullin, Rashid
    Lozovaya, Natalia
    MOLECULAR PAIN, 2016, 12
  • [29] MUSCLE HYPERALGESIA INDUCED BY PERIPHERAL P2X3 RECEPTORS IS MODULATED BY INFLAMMATORY MEDIATORS
    Schiavuzzo, J. G.
    Teixeira, J. M.
    Melo, B.
    da Silva dos Santos, D. F.
    Jorge, C. O.
    Oliveira-Fusaro, M. C. G.
    Parada, C. A.
    NEUROSCIENCE, 2015, 285 : 24 - 33
  • [30] Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications
    Marucci, Gabriella
    Dal Ben, Diego
    Buccioni, Michela
    Navia, Aleix Marti
    Spinaci, Andrea
    Volpini, Rosaria
    Lambertucci, Catia
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (12) : 943 - 963